GEHC(GE HealthCare Technologies Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $17.59B | $18.34B | $19.55B | $19.67B | $20.62B |
| 毛利润 | $7.17B | $7.18B | $7.92B | $8.21B | $8.25B |
| 营业利润 | $2.79B | $2.52B | $2.44B | $2.62B | $2.76B |
| 净利润 | $2.25B | $1.92B | $1.57B | $1.99B | $2.08B |
| 经营现金流 | $1.61B | $2.13B | $2.10B | $1.96B | $1.99B |
| 自由现金流 | $1.36B | $1.82B | $1.71B | $1.55B | $1.50B |
| 摊薄每股收益 | $4.95 | $4.22 | $3.03 | $4.34 | $4.55 |